End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
0.84 CAD | +9.09% | -16.00% | +229.41% |
Apr. 23 | High Tide Up Almost 5% in US Premarket After Reporting Big Jump in Saturday Revenue | MT |
Apr. 23 | High Tide Brief: Reporting Near $2 Million in Retail Sales on '4/20' | MT |
Summary
- The company presents an interesting fundamental situation from a short-term investment perspective.
Strengths
- Its core activity has a significant growth potential and sales are expected to surge, according to Standard & Poor's' forecast. Indeed, those may increase by 54% by 2026.
- The stock, which is currently worth 2024 to 0.48 times its sales, is clearly overvalued in comparison with peers.
- For the last 4 months, the company has been enjoying highly positive EPS revisions, which were frequently and significantly raised.
- Analysts covering this company mostly recommend stock overweighting or purchase.
- The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
- Consensus analysts have strongly revised their opinion of the company over the past 12 months.
Weaknesses
- The company's profitability before interest, taxes, depreciation and amortization characterizes fragile margins.
- Low profitability weakens the company.
- The valuation of the company is particularly high given the cash flows generated by its activity.
- For the last four months, the sales outlook for the coming years has been revised downwards. No recovery of the group's activities is yet foreseen.
- For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.
- Prospects from analysts covering the stock are not consistent. Such dispersed sales estimates confirm the poor visibility into the group's activity.
- The price targets of analysts who cover the stock differ significantly. This implies difficulties in evaluating the company and its business.
- The group usually releases earnings worse than estimated.
Ratings chart - Surperformance
Sector: Drug Retailers
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+229.41% | 159M | - | ||
+13.25% | 2.91B | D+ | ||
+14.12% | 1.69B | - | ||
+3.64% | 485M | - | ||
+13.51% | 108M | - | - | |
-2.98% | 101M | - | ||
+52.81% | 56.96M | - | - |
Financials
Valuation
Momentum
Consensus
Business Predictability
- Stock Market
- Equities
- HITI Stock
- HITI Stock
- Ratings High Tide Inc.